Josh Haipeng Lei

9PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 03, 2026
Hepatocyte IRE1α-XBP1s axis prevents pro-metastatic niche formation through metabolic rewiring of inflammatory monocytes.

|Nov 29, 2025
RAD51B-EZH2 axis as a potential therapeutic target for TNBC through cell fate conversion.

Shiqi Lin, Dongyang Tang, Josh Haipeng Lei

|Jun 26, 2025
α9 Nicotinic Acetylcholine Receptor Promotes Tumor Proliferation and Suppresses Ferroptosis in Triple-Negative Breast Cancer.

Xiaoli Feng, Yuxi Tian, Xijun Guo

|May 15, 2025
Reciprocal stabilization of CtBP and TRIM28 represses autophagy to promote metastasis.

Lixin Tai, Dongliang Zhu, Ping Tang

|Mar 29, 2025
Oncogenic activation of SMYD3-SHCBP1 promotes breast cancer development and is coupled with resistance to immune therapy.

Lihua Mo, Min Deng, Ragini Adhav

|Feb 08, 2024
Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12.

Licen Li, Jianming Zeng, Xin Zhang

Pageof 2

Frequent Collaborators

7 joint publications

Chuxia Deng

3 joint publications

Kai Miao

2 joint publications

Xiaoling Xu

2 joint publications

Xin Zhang